Market Capitalization (Millions $) |
54,342 |
Shares
Outstanding (Millions) |
417 |
Employees |
6,300 |
Revenues (TTM) (Millions $) |
3,622 |
Net Income (TTM) (Millions $) |
542 |
Cash Flow (TTM) (Millions $) |
-76 |
Capital Exp. (TTM) (Millions $) |
237 |
Dexcom Inc
Dexcom Inc. is a medical device company that specializes in developing and manufacturing continuous glucose monitoring (CGM) systems for people with diabetes. The company was founded in 1999 by Scott Krasner and John Wilson.
The company's CGM devices use a sensor that is inserted under the skin to measure the glucose level in the interstitial fluid, which is the fluid that surrounds the cells in the body. The device is connected to a transmitter that wirelessly sends the glucose readings to a receiver, which displays the glucose values in real-time. Dexcom's CGM systems enable people with diabetes to continuously monitor their glucose levels, allowing them to track trends and make better decisions about insulin dosing, diet, and exercise.
Dexcom's CGM systems have been clinically proven to be highly accurate, with a mean absolute difference (MAD) of less than 10% compared to laboratory reference values. The company has also received numerous regulatory approvals and clearances, including FDA approval for the Dexcom G6 system in 2018.
The company has a range of CGM devices, including the Dexcom G6, Dexcom G5, and Dexcom G4 Platinum. The Dexcom G6 is the company's latest CGM system, which features a smaller sensor, longer wear time, and no need for calibration. The device is also compatible with mobile apps, allowing users to receive real-time glucose readings on their smartphones.
Dexcom has a strong focus on research and development, investing heavily in new technologies and features. The company has partnerships with leading diabetes advocacy organizations and universities, working closely with healthcare professionals and patients to develop new products and services to improve diabetes management.
Dexcom has a global presence, with offices and operations in the United States, Europe, Asia, and Australia. The company has a strong reputation in the diabetes community, with a dedicated customer support team and an active online community. Dexcom's vision is to help people with diabetes live their lives to the fullest, using technology to make diabetes management easier, more accurate, and more convenient.
Company Address: 6340 Sequence Drive San Diego 92121 CA
Company Phone Number: 200-0200 Stock Exchange / Ticker: NASDAQ DXCM
|